title: Herpes simplex virus vaccines--where are we?
authors.forename: S
authors.initials: S
authors.lastname: Kit
authors.forename: M
authors.initials: M
authors.lastname: Kit
mesh_terms: D000328:Adult; D000818:Animals; D002644:Chickenpox / Q000517:prevention & control; D002648:Child; D005260:Female; D006558:Herpes Genitalis / Q000517:prevention & control; D006561:Herpes Simplex / Q000517:prevention & control; D008381:Herpesvirus 2, Gallid / Q000276:immunology; D014645:Herpesvirus 3, Human / Q000276:immunology; D006801:Humans; D007231:Infant, Newborn; D008297:Male; D008380:Marek Disease / Q000517:prevention & control; D051379:Mice; D011200:Poultry; D011247:Pregnancy; D012008:Recurrence; D018139:Simplexvirus / Q000235:genetics / Q000276:immunology* / Q000472:pathogenicity; D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014764:Viral Proteins / Q000032:analysis; D014765:Viral Vaccines / Q000145:classification; D014774:Virulence
chemical_list: D014613:Vaccines, Attenuated; D014759:Viral Envelope Proteins; D014764:Viral Proteins; D014765:Viral Vaccines; C039447:glycoprotein D, Human herpesvirus 1